BAT3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.849220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.479250E-03
Normal-vs-Stage2
1.659620E-01
Normal-vs-Stage3
6.575800E-02
Normal-vs-Stage4
1.635760E-01
Stage1-vs-Stage2
1.056350E-02
Stage1-vs-Stage3
5.498800E-01
Stage1-vs-Stage4
1.500320E-02
Stage2-vs-Stage3
1.101600E-01
Stage2-vs-Stage4
6.196200E-01
Stage3-vs-Stage4
1.217210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.899990E-01
Normal-vs-AfricanAmerican
1.365840E-01
Normal-vs-Asian
2.100400E-01
Caucasian-vs-AfricanAmerican
6.672800E-01
Caucasian-vs-Asian
9.254000E-01
AfricanAmerican-vs-Asian
7.204600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.081400E-01
Normal-vs-Female
1.737030E-01
Male-vs-Female
7.373600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.230000E-02
Normal-vs-Age(41-60Yrs)
1.287800E-01
Normal-vs-Age(61-80Yrs)
1.931770E-01
Normal-vs-Age(81-100Yrs)
4.416800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.299000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.612800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.133800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.252400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.510800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.675200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.447000E-01
Normal-vs-Daily Drinker
2.723900E-02
Normal-vs-Weekly Drinker
1.459960E-01
Normal-vs-Occasional Drinker
6.342600E-01
Normal-vs-Social Drinker
6.660100E-02
Non Drinker-vs-Daily Drinker
1.423780E-01
Non Drinker-vs-Weekly Drinker
9.725400E-01
Non Drinker-vs-Occasional Drinker
1.834820E-01
Non Drinker-vs-Social Drinker
8.749600E-01
Daily Drinker-vs-Weekly Drinker
1.328650E-01
Daily Drinker-vs-Occasional Drinker
1.924950E-03
Daily Drinker-vs-Social Drinker
1.279220E-01
Weekly Drinker-vs-Occasional Drinker
1.242550E-01
Weekly Drinker-vs-Social Drinker
9.026600E-01
Occasional Drinker-vs-Social Drinker
7.254000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.460600E-01
Normal-vs-Grade 2
6.728200E-01
Normal-vs-Grade 3
6.522000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.247800E-01
Grade 1-vs-Grade 3
1.455770E-01
Grade 1-vs-Grade 4
7.460600E-01
Grade 2-vs-Grade 3
6.565200E-01
Grade 2-vs-Grade 4
6.728200E-01
Grade 3-vs-Grade 4
6.522000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.191200E-01
Normal-vs-NonDiabetic
1.759040E-01
Diabetic-vs-NonDiabetic
7.402000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.537600E-02
Normal-vs-NoPancreatitis
1.857160E-01
Pancreatitis-vs-NoPancreatitis
8.753800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.200200E-01
Normal-vs-N1
1.438620E-01
N0-vs-N1
1.472810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.341800E-01
Normal-vs-TP53-NonMutant
2.303600E-01
TP53-Mutant-vs-TP53-NonMutant
1.684610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
